| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/28/2008 | US20080051564 Delivery of pharmaceutical agents via the human insulin receptor |
| 02/28/2008 | US20080051563 Fc Variants with Increased Affinity for FcyRIIc |
| 02/28/2008 | US20080051560 Regulation of Gene Expression By Protein Methylation |
| 02/28/2008 | US20080051559 MT-SP1 polypeptides |
| 02/28/2008 | US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods |
| 02/28/2008 | US20080051555 Support Having Affinity for Antibody |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080051322 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors |
| 02/28/2008 | US20080051318 Detecting single nucleotide polymorphism ; kits; drug screening; neurodegenerative disease |
| 02/28/2008 | US20080050841 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 02/28/2008 | US20080050840 Novel protein kinase molecules and uses therefor |
| 02/28/2008 | US20080050825 Method for Production of Transgenic Plants with Increased Pathogenic Resistance by Altering the Content and/or Activity of Actin-Depolymerising Factors |
| 02/28/2008 | US20080050812 Micropositioning Cells For Tissue Engineering |
| 02/28/2008 | US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49 |
| 02/28/2008 | US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
| 02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
| 02/28/2008 | US20080050753 Lipid engineering for analyzing a structure, or functions of a ceramide, diseases associated with the ceramide metabolism; controlling an amount of ceramide in a cell |
| 02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
| 02/28/2008 | US20080050392 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction |
| 02/28/2008 | US20080050391 Method for Treating Autoimmune Diseases With Antibodies |
| 02/28/2008 | US20080050388 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050383 Immunotherapy for clearing pathological tau conformers |
| 02/28/2008 | US20080050381 Antihuman Baff Antibody |
| 02/28/2008 | US20080050380 Glycoprotein VI and uses thereof |
| 02/28/2008 | US20080050379 Cancer gene determination and therapeutic screening using signature gene sets |
| 02/28/2008 | US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents |
| 02/28/2008 | US20080050376 Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells |
| 02/28/2008 | US20080050375 Modulators to transforming growth factors; for disorders related to proliferation and differentiation, migration, apoptosis, embryonic development, extracellular matrix formation, bone development, wound healing, hematopoiesis, and immune and inflammatory responses |
| 02/28/2008 | US20080050374 Immunoglobulin fusion for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050373 Treatment with anti-erbb2 antibodies |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050370 Stabilized polypeptide compositions |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050367 Humanized antibodies that recognize beta amyloid peptide |
| 02/28/2008 | US20080050366 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | US20080050365 Anti-Hiv Antibody |
| 02/28/2008 | US20080050364 Treatment of LFA-1 Associated Disorders with Increasing Doses of LFA-1 Antagonist |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050360 Method of treating a pathological syndrome and a pharmaceutical agent |
| 02/28/2008 | US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 02/28/2008 | US20080050357 Systems and Methods for Antibody Engineering |
| 02/28/2008 | US20080050340 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 02/28/2008 | US20080050311 Monoclonal Antibody hPAM4 |
| 02/28/2008 | US20080050310 Antibodies and immunoconjugates and uses therefor |
| 02/28/2008 | US20080048052 Spray Nozzle Apparatus and Method of Use |
| 02/28/2008 | CA2661814A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | CA2660681A1 Tumor therapy with an anti-vegf antibody |
| 02/28/2008 | CA2660156A1 Anti-c5ar antibodies with improved properties |
| 02/28/2008 | CA2659993A1 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892296A1 Generation and selection of recombinant varied binding proteins |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892249A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891970A1 Beta glucan-based vaccines free of mannoprotein |
| 02/27/2008 | EP1891204A1 Method of fetal cell enrichment |
| 02/27/2008 | EP1891115A2 Anti her2/neu antibody |
| 02/27/2008 | EP1891114A2 Anti-trkb monoclonal antibodies and uses thereof |
| 02/27/2008 | EP1891113A2 Antibodies directed to cd20 and uses thereof |
| 02/27/2008 | EP1891112A1 Methods of using pnkp30, a member of the b7 family, to modulate the immune system |
| 02/27/2008 | EP1891111A1 Il-31 monoclonal antibodies and methods of use |
| 02/27/2008 | EP1891110A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF-alpha |
| 02/27/2008 | EP1891109A1 Cardiovascular disease therapies |
| 02/27/2008 | EP1891108A1 Psp94 diagnostic reagents and assays |
| 02/27/2008 | EP1891107A2 Compositions and methods for modulating immune responses |
| 02/27/2008 | EP1891101A2 Sclerostin binding agents |
| 02/27/2008 | EP1890726A1 Novel analgesic treatment with prolonged effect |
| 02/27/2008 | EP1469879A4 Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
| 02/27/2008 | EP1344821B9 Novel aggrecanase |
| 02/27/2008 | EP1334731B1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1071714B1 A novel g-protein coupled receptor |
| 02/27/2008 | EP0981549B9 Use of an inhibitor substance for the improvement of neuronal regeneration |
| 02/27/2008 | EP0942968B1 Fully human antibodies that bind EGFR |
| 02/27/2008 | EP0739350B1 Ligand that binds fas antigen |
| 02/27/2008 | CN101133158A 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use |
| 02/27/2008 | CN101133085A Assay method for human orotate phosphoribosyltransferase protein |
| 02/27/2008 | CN101133084A Anti-il-1r1 single domain antibodies and therapeutic uses |
| 02/27/2008 | CN101133083A 人源化的抗cd47抗体 Humanized anti-cd47 antibody |
| 02/27/2008 | CN101130765A Reagent kit for detecting syncytial virus of respiratory passage |
| 02/27/2008 | CN101130078A Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| 02/27/2008 | CN101130077A Remedy for spinal injury containing interleukin-6 antagonist |
| 02/27/2008 | CN100371348C Treatment of micro-organism infection |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335751 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/26/2008 | US7335749 Identifying modulators of antitumor activity; diagnosis, prevention and treatment of cancer |
| 02/26/2008 | US7335748 RG1 antibodies and uses thereof |
| 02/26/2008 | US7335747 agent for detecting a cancer, which comprises a monoclonal antibody that specifically binds to a Mina 53 peptide; produced by hybridoma FERM BP-10157 |
| 02/26/2008 | US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 02/26/2008 | US7335745 Vectors with DNA encoding pro polypeptides |
| 02/26/2008 | US7335744 Prostate cancer specific internalizing human antibodies |
| 02/26/2008 | US7335743 Immunoglobulin for use in treatment and prevention of viral infection, glandular, inflammatory, nervous system, blood, skin, cardiovascular and liver disorders; immunotherapy |
| 02/26/2008 | US7335742 Comprising human immunoglobulin g1 fc region; mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 02/26/2008 | US7335741 Diagnosis of lympghomas using nucleic acids; antigen binding zones |
| 02/26/2008 | US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders |